|
FBXO42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.461500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.024500E-04 |
| Normal-vs-Stage2 |
5.810800E-01 |
| Normal-vs-Stage3 |
1.645200E-01 |
| Normal-vs-Stage4 |
4.267400E-01 |
| Stage1-vs-Stage2 |
3.412200E-02 |
| Stage1-vs-Stage3 |
2.269900E-02 |
| Stage1-vs-Stage4 |
5.377100E-03 |
| Stage2-vs-Stage3 |
5.595200E-01 |
| Stage2-vs-Stage4 |
9.338000E-01 |
| Stage3-vs-Stage4 |
5.454600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.677500E-03 |
| Normal-vs-AfricanAmerican |
1.634560E-01 |
| Normal-vs-Asian |
1.217730E-03 |
| Caucasian-vs-AfricanAmerican |
8.011800E-01 |
| Caucasian-vs-Asian |
5.302300E-02 |
| AfricanAmerican-vs-Asian |
7.319800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.878000E-02 |
| Normal-vs-Female |
7.61590000000201E-05 |
| Male-vs-Female |
3.142600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.325800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.039600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.445800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.545400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.670400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.202200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.127200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.999800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.646000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.440400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.08200000362658E-08 |
| Normal-vs-Grade 2 |
6.0140999999958E-05 |
| Normal-vs-Grade 3 |
2.017000E-01 |
| Normal-vs-Grade 4 |
7.346600E-01 |
| Grade 1-vs-Grade 2 |
4.896400E-03 |
| Grade 1-vs-Grade 3 |
1.74192999999878E-05 |
| Grade 1-vs-Grade 4 |
1.59879999994672E-06 |
| Grade 2-vs-Grade 3 |
7.618300E-04 |
| Grade 2-vs-Grade 4 |
1.740640E-03 |
| Grade 3-vs-Grade 4 |
4.345000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.69129999996842E-06 |
| Normal-vs-ccB subtype |
4.079000E-01 |
| ccA subtype-vs-ccB subtype |
9.52889999999984E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.751600E-02 |
| Normal-vs-N1 |
8.277400E-01 |
| N0-vs-N1 |
4.801000E-01 |
|
|
